These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32224336)

  • 41. Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents.
    Onajole OK; Lun S; Yun YJ; Langue DY; Jaskula-Dybka M; Flores A; Frazier E; Scurry AC; Zavala A; Arreola KR; Pierzchalski B; Ayitou AJ; Bishai WR
    Chem Biol Drug Des; 2020 Dec; 96(6):1362-1371. PubMed ID: 32515129
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis, and antitubercular activity of 3-amidophenols with 5-heteroatomic substitutions.
    Zhang NN; Tang YX; Qian L; Gao YM; Liu ZY; Zou ZL; Zhang TY; Yan M
    Arch Pharm (Weinheim); 2019 Apr; 352(4):e1800277. PubMed ID: 30698293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Introduction of Hydrazone, Hydrazide, or Azepane Moieties to the Triterpenoid Core Enhances an Activity Against
    Kazakova OB; Medvedeva NI; Smirnova IE; Lopatina TV; Veselovsky AV
    Med Chem; 2021; 17(2):134-145. PubMed ID: 31939731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Malasala S; Ahmad MN; Akunuri R; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2021 Feb; 212():112996. PubMed ID: 33190958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents.
    Kumar G; Sathe A; Krishna VS; Sriram D; Jachak SM
    Eur J Med Chem; 2018 Sep; 157():1-13. PubMed ID: 30064024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered via amide: Design, synthesis, and in vitro anti-mycobacterial activity evaluation.
    Chen R; Zhang H; Ma T; Xue H; Miao Z; Chen L; Shi X
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2635-2637. PubMed ID: 31358466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and antimycobacterial activity of triterpeni≿ A-ring azepanes.
    Medvedeva NI; Kazakova OB; Lopatina TV; Smirnova IE; Giniyatullina GV; Baikova IP; Kataev VE
    Eur J Med Chem; 2018 Jan; 143():464-472. PubMed ID: 29202408
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo potent BM635 analogue with improved drug-like properties.
    Poce G; Cocozza M; Alfonso S; Consalvi S; Venditti G; Fernandez-Menendez R; Bates RH; Barros Aguirre D; Ballell L; De Logu A; Vistoli G; Biava M
    Eur J Med Chem; 2018 Feb; 145():539-550. PubMed ID: 29335214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles.
    Shingalapur RV; Hosamani KM; Keri RS
    Eur J Med Chem; 2009 Oct; 44(10):4244-8. PubMed ID: 19540630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Syntheses and evaluation of substituted aromatic hydroxamates and hydroxamic acids that target Mycobacterium tuberculosis.
    Majewski MW; Cho S; Miller PA; Franzblau SG; Miller MJ
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4933-4936. PubMed ID: 26037320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and synthesis of novel inhibitors of mycobacterium ATP synthase.
    Surase YB; Samby K; Amale SR; Sood R; Purnapatre KP; Pareek PK; Das B; Nanda K; Kumar S; Verma AK
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3454-3459. PubMed ID: 28587823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
    Wang A; Lv K; Li L; Liu H; Tao Z; Wang B; Liu M; Ma C; Ma X; Han B; Wang A; Lu Y
    Eur J Med Chem; 2019 Sep; 178():715-725. PubMed ID: 31229874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
    Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulfonyl)piperazin-1-yl)benzo[d]isoxazole derivatives.
    Naidu KM; Suresh A; Subbalakshmi J; Sriram D; Yogeeswari P; Raghavaiah P; Chandra Sekhar KV
    Eur J Med Chem; 2014 Nov; 87():71-8. PubMed ID: 25240097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and synthesis of novel benzimidazole derivatives as anti-tuberculosis agents.
    Zhang HY; Wang B; Sheng L; Li D; Zhang DF; Lin ZY; Lu Y; Li Y; Huang HH
    Yao Xue Xue Bao; 2014 May; 49(5):644-51. PubMed ID: 25151735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
    Chhabria MT; Jani MH
    Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, in vitro, and in vivo (Zebra fish) antitubercular activity of 7,8-dihydroquinolin-5(6H)-ylidenehydrazinecarbothioamides.
    Marvadi SK; Krishna VS; Surineni G; Srilakshmi Reshma R; Sridhar B; Sriram D; Kantevari S
    Bioorg Chem; 2020 Mar; 96():103626. PubMed ID: 32007719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Azide-alkyne cycloaddition towards 1H-1,2,3-triazole-tethered gatifloxacin and isatin conjugates: Design, synthesis and in vitro anti-mycobacterial evaluation.
    Xu Z; Song XF; Hu YQ; Qiang M; Lv ZS
    Eur J Med Chem; 2017 Sep; 138():66-71. PubMed ID: 28646656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents.
    Mhiri C; Boudriga S; Askri M; Knorr M; Sriram D; Yogeeswari P; Nana F; Golz C; Strohmann C
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4308-13. PubMed ID: 26271585
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Deb PK; Al-Shar'i NA; Venugopala KN; Pillay M; Borah P
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):869-884. PubMed ID: 34060396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.